Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Abbott says combination assay could help identify acute HIV

Abbott says combination assay could help identify acute HIV

10th February 2009

Abbott has said a new combination assay could be useful when screening individuals for acute HIV.

The company conducted research with Johns Hopkins University and others, and presented its results at a recent conference.

It explained that in many cases, acute HIV infection is missed by traditional tests because the antibody response has not yet developed in the host.

However, the new antigen-antibody combination assay can help high-volume identification of this reliably and cost-effectively, according to Abbott.

Tests using the assay detected 61.9 per cent of early infection in a high-risk group, a statement from the firm said.

This compared to the 14.3 per cent discovered by a third-generation antibody test.

According to Dr John Hackett of Abbott’s global HIV surveillance programme, the results suggest “that this test can be useful for high-volume public health outreach screening to identify acute HIV infections”.

NHS statistics put the number of HIV sufferers in the UK at 73,000.

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.